Cargando…

Formative usability evaluation of a fixed-dose pen-injector platform device

BACKGROUND: This article for the first time presents a formative usability study of a fixed-dose pen injector platform device used for the subcutaneous delivery of biopharmaceuticals, primarily for self-administration by the patient. The study was conducted with a user population of both naïve and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lange, Jakob, Nemeth, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894723/
https://www.ncbi.nlm.nih.gov/pubmed/29670411
http://dx.doi.org/10.2147/MDER.S159733
_version_ 1783313543420968960
author Lange, Jakob
Nemeth, Tobias
author_facet Lange, Jakob
Nemeth, Tobias
author_sort Lange, Jakob
collection PubMed
description BACKGROUND: This article for the first time presents a formative usability study of a fixed-dose pen injector platform device used for the subcutaneous delivery of biopharmaceuticals, primarily for self-administration by the patient. The study was conducted with a user population of both naïve and experienced users across a range of ages. The goals of the study were to evaluate whether users could use the devices safely and effectively relying on the instructions for use (IFU) for guidance, as well as to benchmark the device against another similar injector established in the market. Further objectives were to capture any usability issues and obtain participants’ subjective ratings on the properties and performance of both devices. METHODS: A total of 20 participants in three groups studied the IFU and performed simulated injections into an injection pad. RESULTS: All participants were able to use the device successfully. The device was well appreciated by all users with, maximum usability feedback scores reported by 90% or more on handling forces and device feedback, and by 85% or more on fit and grip of the device. The presence of clear audible and visible feedbacks upon successful loading of a dose and completion of injection was seen to be a significant improvement over the benchmark injector. CONCLUSION: The observation that the platform device can be safely and efficiently used by all user groups provides confidence that the device and IFU in their current form will pass future summative testing in specific applications.
format Online
Article
Text
id pubmed-5894723
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-58947232018-04-18 Formative usability evaluation of a fixed-dose pen-injector platform device Lange, Jakob Nemeth, Tobias Med Devices (Auckl) Original Research BACKGROUND: This article for the first time presents a formative usability study of a fixed-dose pen injector platform device used for the subcutaneous delivery of biopharmaceuticals, primarily for self-administration by the patient. The study was conducted with a user population of both naïve and experienced users across a range of ages. The goals of the study were to evaluate whether users could use the devices safely and effectively relying on the instructions for use (IFU) for guidance, as well as to benchmark the device against another similar injector established in the market. Further objectives were to capture any usability issues and obtain participants’ subjective ratings on the properties and performance of both devices. METHODS: A total of 20 participants in three groups studied the IFU and performed simulated injections into an injection pad. RESULTS: All participants were able to use the device successfully. The device was well appreciated by all users with, maximum usability feedback scores reported by 90% or more on handling forces and device feedback, and by 85% or more on fit and grip of the device. The presence of clear audible and visible feedbacks upon successful loading of a dose and completion of injection was seen to be a significant improvement over the benchmark injector. CONCLUSION: The observation that the platform device can be safely and efficiently used by all user groups provides confidence that the device and IFU in their current form will pass future summative testing in specific applications. Dove Medical Press 2018-04-04 /pmc/articles/PMC5894723/ /pubmed/29670411 http://dx.doi.org/10.2147/MDER.S159733 Text en © 2018 Lange and Nemeth. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Lange, Jakob
Nemeth, Tobias
Formative usability evaluation of a fixed-dose pen-injector platform device
title Formative usability evaluation of a fixed-dose pen-injector platform device
title_full Formative usability evaluation of a fixed-dose pen-injector platform device
title_fullStr Formative usability evaluation of a fixed-dose pen-injector platform device
title_full_unstemmed Formative usability evaluation of a fixed-dose pen-injector platform device
title_short Formative usability evaluation of a fixed-dose pen-injector platform device
title_sort formative usability evaluation of a fixed-dose pen-injector platform device
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894723/
https://www.ncbi.nlm.nih.gov/pubmed/29670411
http://dx.doi.org/10.2147/MDER.S159733
work_keys_str_mv AT langejakob formativeusabilityevaluationofafixeddosepeninjectorplatformdevice
AT nemethtobias formativeusabilityevaluationofafixeddosepeninjectorplatformdevice